Is PhRMA reneging on statements its chair made about a “deal” with the White House to prevent Medicare from negotiating with Pharma as part of Obama’s health reform package? The lobby’s vice president is refuting claims that chairman (and former Louisiana congressman) Billy Tauzin confirmed a deal had been reached between the two parties that would leverage the government’s spending on drugs beyond an agreed amount of cost savings over the course of a decade.

At stake is over $150 million in ads by the influential lobby supporting the Obama administration’s efforts at reform. If Congress decides to pass legislation prohibiting industry price controls at the hands of Pharma, allowing Medicare to negotiate prices across the board, could this be a PR firestorm just waiting to happen for either side? The president may have gained support from Pharma for his reforms, but at what potential costs to him, fellow Democrats, and his constituency? | LINK

Related Posts Within Doctor Pundit:

1. Drug Lobby Exposes White House Deal on Pharma Portion of Reform Bill The White House has another damage control problem on its...
2. Obama & White House: Healthcare Reform Will Pass As the month of September begins, the rather surreal period...
3. White House Releases Statement on Public Option ‘Rumors’, Some Top Dems Unconvinced The President’s drive for a public option is rife with...
4. White House Officially Endorses Composite House Healthcare Reform Bill Take it for what it’s worth — and that really...
5. White House on Side of Pharma in Lawsuit Concerning Drug Prices Are there pharmaceutical companies that are accused of overcharging public...